Lapatinib and the treatment of metastatic breast cancer treated by trastuzumab

Abstract

Clinical testing of patients with advanced or metastatic breast cancer. Clinical response was evaluated at regular eight-week intervals.

Keywords

• Lapatinib
• breast cancer
• metastasis
• treatment